Recruiting Breast Cancer Studies in Alhambra
Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors
This phase II trial tests how well fisetin and exercise works in preventing frailty in breast cancer survivors. Fisetin is a natural substance found in strawberries and other foods and is available as...
Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors
This phase II trial tests whether fisetin works to improve physical function in women who have received chemotherapy for stage I-III breast cancer treatment. Fisetin is a naturally occurring substance...
About Breast Cancer Clinical Trials in Alhambra
Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.
There are currently 2 breast cancer clinical trials recruiting participants in Alhambra, CALIFORNIA. These studies are seeking a combined 252 participants. Research is being sponsored by Jonsson Comprehensive Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.
Breast Cancer Clinical Trials in Alhambra — FAQ
Are there breast cancer clinical trials in Alhambra?
Yes, there are 2 breast cancer clinical trials currently recruiting in Alhambra, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Alhambra?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Alhambra research site will contact you about next steps.
Are clinical trials in Alhambra free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Alhambra studies also compensate for your time and travel.
What breast cancer treatments are being tested?
The 2 active trials in Alhambra are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.
Data updated March 2, 2026 from ClinicalTrials.gov